GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD. Funds and ETFs Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Equities
002317
CNE100000HW4
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.9 CNY | +2.19% |
|
+3.98% | -7.17% |
| Apr. 22 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 11 | Zhongsheng Pharma's Chairman to Raise Stake in Company | MT |
ETFs positioned on Guangdong Zhongsheng Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Guangdong Zhongsheng Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of medicines. The Companyâs medicine products are categorized into Chinese patent medicines, chemical drugs, chemical bulk drugs and herbal decoction pieces, which include capsules for thrombus, pellets for upper respiratory tract diseases, granular for sunstroke, compound dexamethasone acetate creams and azelastine hydrochloride eye drops, among others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Annual General Meeting
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
14.9
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.17% | 1.74B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002317 Stock
- Funds and ETFs Guangdong Zhongsheng Pharmaceutical Co., Ltd.
